Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

BAVENCIO Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: BAVENCIO

Patents:	21
Applicants:	1
BLAs:	2
Suppliers: see list	1

US Patents for BAVENCIO

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INTRAVENOUS	761078	001	2017-05-09	Start Trial	Yeda Research and Development Co. Ltd. (Rehovot, IL)	2034-03-12	RX		search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INTRAVENOUS	761078	001	2017-05-09	Start Trial	Yeda Research and Development Co. Ltd. (Rehovot, IL)	2034-03-12	RX		search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INTRAVENOUS	761078	001	2017-05-09	Start Trial	Yeda Research and Development Co. Ltd. (Rehovot, IL)	2034-03-12	RX		search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INTRAVENOUS	761078	001	2017-05-09	Start Trial	IBC Pharmaceuticals, Inc. (Morris Plains, NJ)	2032-08-14	RX		search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INTRAVENOUS	761078	001	2017-05-09	Start Trial	Biomed Valley Discoveries, Inc. (Kansas City, MO)	2035-06-29	RX		search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INTRAVENOUS	761078	001	2017-05-09	Start Trial		2037-10-04	RX		search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INTRAVENOUS	761078	001	2017-05-09	Start Trial		2036-02-11	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for BAVENCIO

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
European Patent Office	1720996	Start Trial
Japan	2010515732	Start Trial
European Patent Office	3322443	Start Trial
Japan	2019518741	Start Trial
European Patent Office	2473187	Start Trial
Australia	2011336396	Start Trial
China	102448494	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Johnson and Johnson

Baxter

Merck

Moodys

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.